Navigation Links
Stroke-preventing technology demonstrated in JoVE
Date:2/28/2012

In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million Americans will be affected by 2050. The most devastating side effect of AF is stroke, but a new device from Boston Scientific may prevent them from occurring.

Researchers from Atritech, now part of Boston Scientific, developed the WATCHMAN device, a small mesh umbrella that can be inserted into part of the heart cavity to prevent the formation of blood clots that cause strokes.

Currently, the anti-coagulant drug warfarin is used to prevent strokes, but the drug comes with other risks.

Warfarin has a lot of side-effects. One major side-effect is the bleeding risk, said paper author Dr. Sven Mobius-Winkler. Therefore, only 50 percent of the patients who should take Warfarin actually take it.

The WATCHMAN device gives patients another option. It has already been approved for use in the European Union and Australia, and secured investigational approval from the FDA in 2009.

To help train doctors how to use the device, doctors from the University of Leipzig Heart Center in Germany are publishing the full WATCHMAN placement procedure in the Journal of Visualized Experiments (JoVE), the worlds first and only peer-reviewed, PubMed indexed, science and medicine video journal.

Intervention and closure of the left atrial appendage is a complex procedure, said Dr. Mobius- Winkler. For inexperienced physicians, it is hard to learn this procedure and therefore the video can help by doing step-by-step the implantation.

The WATCHMAN device will give patients with atrial fibrillation another option rather than anti-coagulant drugs, said JoVE Editor Dr. Robert Dolan. This article demonstrates the implantation of the device and will help clinicians gain expertise with the procedure, helping many of the patients who are unable or unwilling to take warfarin.


'/>"/>

Contact: Katherine Scott
katherine.scott@jove.com
617-820-1817
The Journal of Visualized Experiments
Source:Eurekalert  

Related medicine news :

1. Development of social technology to improve the quality of life of intellectually disabled people
2. New technology to tackle treatment-resistant cancers
3. Research finds newer radiation therapy technology improves patients quality of life
4. American College of Physicians, CECity launch new quality improvement technology platform
5. Patients at risk of knee joint complications when new technology is used
6. Notre Dame, Purdue and GE Healthcare partner on new CT technology
7. Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU
8. Combined arterial imaging technology reveals both structural and metabolic details
9. Health Information Technology and Patient Safety - IOM report releases Nov. 10
10. Modern Technology Reveals Clues From Egyptian Mummy
11. Federal government releases environmental, health, and safety research strategy for nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stroke-preventing technology demonstrated in JoVE
(Date:3/27/2017)... ... 27, 2017 , ... Drs. Bruce Trimble and Michelle Parker ... a referral. Trimble Dental offers a variety of services to meet each patient’s ... patients have discolored, crooked or missing teeth in Eau Claire, WI, Drs. Trimble ...
(Date:3/27/2017)... Austin, TX (PRWEB) , ... March 27, 2017 , ... ... , Edward Buckingham MD, and his colleague, Sudeep Roy, MD, was recently published ... on Bipolar Electrocautery Efficacy in Rhytidectomy” details Drs. Buckingham and Roy’s study on the ...
(Date:3/27/2017)... ... 27, 2017 , ... The Case Management Society of America (CMSA) will install ... CMSA’s membership has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to ... new VA Advisory position has also been added to the BOD, per an appointment ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek ... to pursue the recent RNA methylation “gold rush” with their established portfolio of ... newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has received a ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office ... First National Capital has added 10 new sales professionals over the past 6 months ... by 15 additional new hires over the course of 2017. , “This new ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017 On Friday, benchmark US ... closed the trading session up 0.19%; the Dow Jones ... was down 0.08%. US markets made broad based gains ... in green. Pre-market today, Stock-Callers.com reviews these four Medical ... WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: ...
(Date:3/27/2017)... , March 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... Paul M. Bisaro as Impax,s President and ... Board, effective March 27, 2017. Mr. Bisaro will succeed ... Interim President and Chief Executive Officer since December of ... and branded pharmaceutical experience, Mr. Bisaro, 56, is an ...
(Date:3/27/2017)... , March 27, 2017 Arena Pharmaceuticals, Inc. ... on developing novel, small molecule drugs across multiple therapeutic areas, ... Chief Executive Officer, will present a corporate update at the ... 3:40pm ET.  The conference will take place April 4-5, 2017 ... New York , NY.  A live ...
Breaking Medicine Technology: